3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 3,424 | 422.45 | 0 | 8 | 311 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -4,526 | 558.44 | 0 | -8 | -43 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 345 | 245.79 | 0 | 1 | 18 | 9 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -790 | 562.98 | 0 | -1 | -13 | 9 | D | | | | | | | | | | | | | | |
2/22/24 17:02 | 2/21/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 206.94 | 0 | 0 | 1 | 82 | D | | | | | | | | | | | | | | |
2/20/24 17:01 | 2/16/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 9 | 6 | D | | | | | | | | | | | | | | |
2/20/24 17:00 | 2/15/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 100 | 206.94 | 0 | 0 | 1 | 49 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 244 | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 88 | 1 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 11 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 4 | 48 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 4 | 5 | 82 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 15 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP,CHRO | M.d | 0 | 0.00 | 0 | 0 | 999% | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 6 | 12 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 0 | 6 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:54 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 5 | 11 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 608 | 62.00 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | S.d | -4,705 | 573.87 | 0 | -8 | -55 | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 3,303 | 141.60 | 0 | 23 | 95 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | S.d | -13,296 | 570.01 | 0 | -23 | -33 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 814 | 67.85 | 0 | 12 | 18 | 79 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,871 | 572.61 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,955 | 253.92 | 0 | 12 | | 10 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -6,072 | 521.79 | 0 | -12 | -54 | 10 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 20 | 79 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -3,657 | 513.05 | 0 | -7 | -8 | 79 | D | | | | | | | | | | | | | | |
11/8/23 17:09 | 11/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 231 | 133.76 | 0 | 2 | 37 | 6 | D | | | | | | | | | | | | | | |
9/6/23 17:01 | 9/1/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 9 | 0 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 23 | 73 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,873 | 512.01 | 0 | -13 | -16 | 73 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,438 | 144.21 | 0 | 17 | | 10 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -11,696 | 510.56 | 0 | -23 | -70 | 10 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | 0 | 0.00 | 0 | 0 | 0 | 596 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 0 | 48 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 73 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 3,005 | 187.47 | 0 | 16 | | 5 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -8,174 | 510.00 | 0 | -16 | -78 | 5 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 1,591 | 79.54 | 0 | 20 | 3 | 597 | D | | | | | | | | | | | | | | |
5/22/23 17:00 | 5/18/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -9,806 | 490.29 | 0 | -20 | -3 | 597 | D | | | | | | | | | | | | | | |
5/15/23 17:32 | 5/11/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 9 | D | | | | | | | | | | | | | | |
5/15/23 17:32 | 5/11/23 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 6 | 6 | D | | | | | | | | | | | | | | |
5/15/23 17:32 | 5/11/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 6 | 9 | D | | | | | | | | | | | | | | |
5/15/23 17:31 | 5/11/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 25 | 2 | D | | | | | | | | | | | | | | |
5/15/23 17:31 | 5/11/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Asha | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 193 | 1 | D | | | | | | | | | | | | | | |
5/15/23 17:31 | 5/11/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 2 | 0 | 601 | D | | | | | | | | | | | | | | |
5/11/23 17:01 | 5/10/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 178.26 | 0 | 1 | 0 | 602 | D | | | | | | | | | | | | | | |
5/8/23 17:04 | 5/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 13 | 4 | D | | | | | | | | | | | | | | |
5/8/23 17:03 | 5/5/23 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -950 | 474.90 | 0 | -2 | -25 | 6 | I | | | | | | | | | | | | | | |
5/8/23 17:02 | 5/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 100 | 178.26 | 0 | 1 | 1 | 48 | D | | | | | | | | | | | | | | |
5/8/23 17:01 | 5/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S | -484 | 484.00 | 0 | -1 | -18 | 5 | D | | | | | | | | | | | | | | |
5/5/23 18:01 | 5/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 452 | 206.62 | 0 | 2 | 32 | 9 | M | | | | | | | | | | | | | | |
5/5/23 18:01 | 5/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -1,026 | 469.02 | 0 | -2 | -19 | 9 | M | | | | | | | | | | | | | | |
5/5/23 18:00 | 5/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 178.26 | 0 | 1 | 1 | 73 | D | | | | | | | | | | | | | | |
2/17/23 17:06 | 2/16/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 452 | 206.62 | 0 | 2 | 275 | 3 | D | | | | | | | | | | | | | | |
2/17/23 17:06 | 2/16/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,119 | 511.68 | 0 | -2 | -42 | 3 | D | | | | | | | | | | | | | | |
2/17/23 17:04 | 2/15/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.dm | -515 | 510.09 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
2/17/23 17:04 | 2/16/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 1 | 79.54 | 0 | 0 | 0 | 7 | D | | | | | | | | | | | | | | |
2/16/23 18:56 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 0 | 0.00 | 0 | 1 | 37 | 4 | D | | | | | | | | | | | | | | |
2/16/23 18:56 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 159 | 58.23 | 0 | 3 | 58 | 7 | D | | | | | | | | | | | | | | |
2/16/23 18:56 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -1,009 | 504.59 | 0 | -2 | -21 | 7 | D | | | | | | | | | | | | | | |
2/16/23 18:55 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 481 | 0 | D | | | | | | | | | | | | | | |
2/16/23 18:54 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 5 | 16 | D | | | | | | | | | | | | | | |
2/16/23 18:53 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 4 | 47 | D | | | | | | | | | | | | | | |
2/16/23 18:52 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 4 | 5 | 73 | D | | | | | | | | | | | | | | |
2/16/23 18:51 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 20 | 6 | D | | | | | | | | | | | | | | |
2/16/23 18:51 | 2/14/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 8 | 11 | D | | | | | | | | | | | | | | |
2/13/23 17:01 | 2/9/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 80 | 79.54 | 0 | 1 | 17 | 7 | D | | | | | | | | | | | | | | |
2/13/23 17:01 | 2/9/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -505 | 505.04 | 0 | -1 | -12 | 7 | D | | | | | | | | | | | | | | |
2/10/23 17:00 | 2/9/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 100 | 141.60 | 0 | 1 | 7 | 11 | D | | | | | | | | | | | | | | |
12/7/22 16:30 | 12/5/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 488 | 160.28 | 0 | 3 | | 3 | D | | | | | | | | | | | | | | |
12/7/22 16:30 | 12/5/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,294 | 424.91 | 0 | -3 | -51 | 3 | D | | | | | | | | | | | | | | |
12/6/22 17:01 | 12/2/22 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 321 | 160.28 | 0 | 2 | 30 | 9 | D | | | | | | | | | | | | | | |
12/6/22 17:01 | 12/2/22 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S.d | -317 | 428.55 | 0 | -1 | -8 | 9 | D | | | | | | | | | | | | | | |
12/5/22 17:00 | 12/1/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 425 | 141.60 | 0 | 3 | 75 | 7 | D | | | | | | | | | | | | | | |
12/5/22 17:00 | 12/1/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.d | -1,308 | 436.00 | 0 | -3 | -30 | 7 | D | | | | | | | | | | | | | | |
11/16/22 17:00 | 11/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,178 | 62.00 | 0 | 19 | 37 | 71 | D | | | | | | | | | | | | | | |
11/16/22 17:00 | 11/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -4,562 | 434.47 | 0 | -11 | -13 | 71 | D | | | | | | | | | | | | | | |
11/14/22 17:00 | 11/10/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.dm | 2,626 | 189.23 | 0 | 14 | | 7 | D | | | | | | | | | | | | | | |
11/14/22 17:00 | 11/10/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.dm | -5,921 | 426.71 | 0 | -14 | -66 | 7 | D | | | | | | | | | | | | | | |
11/9/22 17:00 | 11/7/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,248 | 52.00 | 0 | 24 | 63 | 62 | D | | | | | | | | | | | | | | |
11/9/22 17:00 | 11/7/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -5,060 | 382.49 | 0 | -13 | -18 | 62 | D | | | | | | | | | | | | | | |
9/6/22 17:00 | 9/1/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 79 | 0 | D | | | | | | | | | | | | | | |
8/8/22 17:01 | 8/5/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 0 | 0 | 46 | D | | | | | | | | | | | | | | |
8/8/22 17:00 | 8/5/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 52 | D | | | | | | | | | | | | | | |
5/23/22 17:00 | 5/20/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 141.60 | 0 | 1 | 1 | 51 | D | | | | | | | | | | | | | | |
5/13/22 17:59 | 5/11/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 2 | 10 | D | | | | | | | | | | | | | | |
5/13/22 17:58 | 5/11/22 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 3 | 7 | D | | | | | | | | | | | | | | |
5/13/22 17:56 | 5/11/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 19 | 1 | D | | | | | | | | | | | | | | |
5/13/22 17:43 | 5/11/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 8 | D | | | | | | | | | | | | | | |
5/13/22 17:36 | 5/11/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 0 | 640 | D | | | | | | | | | | | | | | |
2/22/22 17:01 | 2/18/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 200 | 91.73 | 0 | 2 | 45 | 7 | D | | | | | | | | | | | | | | |
2/22/22 17:00 | 2/18/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 141.60 | 0 | 1 | 0 | 640 | D | | | | | | | | | | | | | | |
2/18/22 17:01 | 2/17/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 19 | 3 | D | | | | | | | | | | | | | | |
2/17/22 17:49 | 2/16/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 100 | 141.60 | 0 | 1 | 2 | 46 | D | | | | | | | | | | | | | | |
2/17/22 17:48 | 2/15/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -127 | 509.70 | 0 | 0 | 0 | 639 | D | | | | | | | | | | | | | | |
2/16/22 19:29 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 0 | 0.00 | 0 | 1 | 50 | 3 | D | | | | | | | | | | | | | | |
2/16/22 19:28 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | SVP | M.d | 0 | 0.00 | 0 | 1 | 5 | 18 | D | | | | | | | | | | | | | | |
2/16/22 19:28 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 0 | 0.00 | 0 | 1 | 22 | 5 | D | | | | | | | | | | | | | | |
2/16/22 19:26 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 5 | 15 | D | | | | | | | | | | | | | | |
2/16/22 19:25 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 5 | 45 | D | | | | | | | | | | | | | | |
2/16/22 19:24 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 3 | 6 | 51 | D | | | | | | | | | | | | | | |
2/16/22 19:23 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 23 | 5 | D | | | | | | | | | | | | | | |
2/16/22 19:22 | 2/14/22 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 7 | 10 | D | | | | | | | | | | | | | | |
12/1/21 17:01 | 11/29/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S | -2,909 | 633.00 | 0 | -5 | -24 | 15 | D | | | | | | | | | | | | | | |
11/15/21 17:00 | 11/12/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 626 | 67.85 | 0 | 9 | 26 | 44 | D | | | | | | | | | | | | | | |
11/15/21 17:00 | 11/12/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S.d | -5,726 | 620.73 | 0 | -9 | -17 | 44 | D | | | | | | | | | | | | | | |
11/12/21 17:29 | 11/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 1,357 | 67.85 | 0 | 20 | 82 | 44 | D | | | | | | | | | | | | | | |
11/12/21 17:29 | 11/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S.d | -12,499 | 624.96 | 0 | -20 | -31 | 44 | D | | | | | | | | | | | | | | |
11/10/21 17:31 | 11/8/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.dm | 1,107 | 67.85 | 0 | 16 | 58 | 44 | D | | | | | | | | | | | | | | |
11/10/21 17:31 | 11/8/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S.dm | -10,260 | 629.05 | 0 | -16 | -27 | 44 | D | | | | | | | | | | | | | | |
10/13/21 17:01 | 10/11/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | M.d | 308 | 160.28 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
9/2/21 17:03 | 8/31/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 100 | 79.54 | 0 | 1 | 42 | 4 | D | | | | | | | | | | | | | | |
8/31/21 17:01 | 8/27/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.dm | 197 | 77.87 | 0 | 3 | 562 | 3 | D | | | | | | | | | | | | | | |
8/31/21 17:01 | 8/27/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.dm | -1,733 | 686.22 | 0 | -3 | -46 | 3 | D | | | | | | | | | | | | | | |
8/31/21 17:01 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.a | -1,117 | 558.44 | 0 | -2 | -40 | 3 | D | | | | | | | | | | | | | | |
8/17/21 17:02 | 8/13/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.m | -4,051 | 675.21 | 0 | -6 | -11 | 49 | D | | | | | | | | | | | | | | |
8/12/21 17:01 | 8/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 204 | 85.00 | 0 | 2 | 486 | 3 | D | | | | | | | | | | | | | | |
8/12/21 17:01 | 8/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,632 | 679.58 | 0 | -2 | -45 | 3 | D | | | | | | | | | | | | | | |
8/12/21 17:00 | 8/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 100 | 90.32 | 0 | 1 | 14 | 9 | D | | | | | | | | | | | | | | |
8/9/21 17:02 | 8/6/21 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -2,064 | 687.87 | 0 | -3 | -29 | 7 | I | | | | | | | | | | | | | | |
8/9/21 17:01 | 8/5/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 0 | 0 | 44 | D | | | | | | | | | | | | | | |
8/9/21 17:01 | 8/5/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 55 | D | | | | | | | | | | | | | | |
8/9/21 17:00 | 8/5/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 74 | 137.90 | 0 | 1 | 7 | 8 | D | | | | | | | | | | | | | | |
8/9/21 17:00 | 8/5/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S.d | -378 | 703.00 | 0 | -1 | -6 | 8 | D | | | | | | | | | | | | | | |
8/5/21 17:02 | 8/3/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | SVP | M.dm | 3,455 | 168.92 | 0 | 20 | | 17 | D | | | | | | | | | | | | | | |
8/5/21 17:02 | 8/3/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | SVP | S.dm | -14,171 | 698.25 | 0 | -20 | -54 | 17 | D | | | | | | | | | | | | | | |
8/5/21 17:01 | 8/3/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 802 | 114.59 | 0 | 7 | | 4 | D | | | | | | | | | | | | | | |
8/5/21 17:01 | 8/3/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -4,841 | 691.62 | 0 | -7 | -62 | 4 | D | | | | | | | | | | | | | | |
6/1/21 18:01 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S | -1,117 | 558.44 | 0 | -2 | -40 | 3 | D | | | | | | | | | | | | | | |
6/1/21 18:01 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 679 | 67.85 | 0 | 10 | 101 | 20 | D | | | | | | | | | | | | | | |
6/1/21 18:01 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -5,619 | 561.91 | 0 | -10 | -33 | 20 | D | | | | | | | | | | | | | | |
6/1/21 18:00 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 752 | 79.54 | 0 | 9 | 1 | 655 | D | | | | | | | | | | | | | | |
6/1/21 18:00 | 5/28/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -5,319 | 562.26 | 0 | -9 | -1 | 655 | D | | | | | | | | | | | | | | |
5/26/21 17:31 | 5/24/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S | -1,584 | 546.24 | 0 | -3 | -37 | 5 | D | | | | | | | | | | | | | | |
5/26/21 17:30 | 5/24/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.dm | 795 | 79.54 | 0 | 10 | 2 | 664 | D | | | | | | | | | | | | | | |
5/26/21 17:30 | 5/24/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.dm | -5,496 | 549.57 | 0 | -10 | -1 | 664 | D | | | | | | | | | | | | | | |
5/24/21 18:15 | 5/21/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 213 | 85.00 | 0 | 3 | 648 | 3 | D | | | | | | | | | | | | | | |
5/24/21 18:15 | 5/21/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,349 | 539.57 | 0 | -3 | -46 | 3 | D | | | | | | | | | | | | | | |
5/24/21 18:15 | 5/20/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | S.m | -1,620 | 540.00 | 0 | -3 | -28 | 8 | D | | | | | | | | | | | | | | |
5/24/21 18:14 | 5/20/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 398 | 79.54 | 0 | 5 | 1 | 664 | D | | | | | | | | | | | | | | |
5/24/21 18:14 | 5/20/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -2,685 | 537.07 | 0 | -5 | -1 | 664 | D | | | | | | | | | | | | | | |
5/20/21 17:33 | 5/18/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 607 | 79.54 | 0 | 8 | 1 | 664 | D | | | | | | | | | | | | | | |
5/20/21 17:33 | 5/18/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -4,030 | 528.02 | 0 | -8 | -1 | 664 | D | | | | | | | | | | | | | | |
5/12/21 19:47 | 5/10/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -277 | 541.02 | 0 | -1 | 0 | 664 | D | | | | | | | | | | | | | | |
3/1/21 17:06 | 2/26/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | SVP | M.d | 219 | 67.85 | 0 | 3 | 24 | 17 | D | | | | | | | | | | | | | | |
3/1/21 17:05 | 2/25/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 100 | 67.85 | 0 | 1 | 8 | 20 | D | | | | | | | | | | | | | | |
2/25/21 19:35 | 2/23/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson Rebecca M | ME | D | | M.d | 488 | 160.28 | 0 | 3 | 26 | 15 | D | | | | | | | | | | | | | | |
2/25/21 19:35 | 2/23/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson Rebecca M | ME | D | | S.d | -1,564 | 513.41 | 0 | -3 | -17 | 15 | D | | | | | | | | | | | | | | |
2/25/21 19:34 | 2/23/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 100 | 67.85 | 0 | 1 | 0 | 664 | D | | | | | | | | | | | | | | |
2/24/21 17:01 | 2/22/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | SVP,Gen. | M.d | 100 | 206.94 | 0 | 0 | 35 | 2 | D | | | | | | | | | | | | | | |
2/24/21 17:01 | 2/22/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 67.85 | 0 | 1 | 3 | 56 | D | | | | | | | | | | | | | | |
2/24/21 17:00 | 2/22/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 156 | 82.42 | 0 | 2 | 194 | 3 | D | | | | | | | | | | | | | | |
2/24/21 17:00 | 2/22/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,022 | 538.57 | 0 | -2 | -40 | 3 | D | | | | | | | | | | | | | | |
2/22/21 18:00 | 2/18/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 80 | 79.54 | 0 | 1 | 0 | 663 | D | | | | | | | | | | | | | | |
2/22/21 18:00 | 2/18/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -556 | 555.56 | 0 | -1 | 0 | 663 | D | | | | | | | | | | | | | | |
2/19/21 17:01 | 2/18/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 100 | 67.85 | 0 | 1 | 3 | 44 | D | | | | | | | | | | | | | | |
2/19/21 17:00 | 2/17/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,300 | 52.00 | 0 | 25 | 86 | 54 | D | | | | | | | | | | | | | | |
2/19/21 17:00 | 2/17/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -7,450 | 537.21 | 0 | -14 | -20 | 54 | D | | | | | | | | | | | | | | |
2/18/21 19:26 | 2/16/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | M.d | 682 | 97.05 | 0 | 7 | | 0 | D | | | | | | | | | | | | | | |
2/18/21 19:26 | 2/16/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | S.d | -3,936 | 536.91 | 0 | -7 | -100 | 0 | D | | | | | | | | | | | | | | |
2/17/21 19:35 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | SVP,Gen. | M.d | 0 | 0.00 | 0 | 1 | 101 | 1 | D | | | | | | | | | | | | | | |
2/17/21 19:35 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | SVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 14 | D | | | | | | | | | | | | | | |
2/17/21 19:34 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | M.d | 0 | 0.00 | 0 | 1 | 10 | 11 | D | | | | | | | | | | | | | | |
2/17/21 19:34 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 6 | 18 | D | | | | | | | | | | | | | | |
2/17/21 19:33 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 3 | 7 | 43 | D | | | | | | | | | | | | | | |
2/17/21 19:33 | 2/16/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S.d | -705 | 539.58 | 0 | -1 | -3 | 43 | D | | | | | | | | | | | | | | |
2/17/21 19:31 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 3 | 8 | 43 | D | | | | | | | | | | | | | | |
2/17/21 19:31 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 30 | 4 | D | | | | | | | | | | | | | | |
2/17/21 19:31 | 2/16/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -463 | 545.00 | 0 | -1 | -17 | 4 | D | | | | | | | | | | | | | | |
2/17/21 19:30 | 2/14/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 8 | D | | | | | | | | | | | | | | |
2/16/21 17:00 | 2/12/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 488 | 160.28 | 0 | 3 | 49 | 9 | D | | | | | | | | | | | | | | |
2/16/21 17:00 | 2/12/21 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -1,639 | 538.20 | 0 | -3 | -25 | 9 | D | | | | | | | | | | | | | | |
2/8/21 18:05 | 2/4/21 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 888 | 74.78 | 0 | 12 | | 10 | M | | | | | | | | | | | | | | |
2/8/21 18:05 | 2/4/21 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S.d | -5,816 | 489.71 | 0 | -12 | -54 | 10 | M | | | | | | | | | | | | | | |
12/11/20 17:00 | 11/2/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.am | -8,958 | 438.43 | 0 | -20 | -3 | 727 | D | | | | | | | | | | | | | | |
12/2/20 17:01 | 11/30/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | M.d | 869 | 67.85 | 0 | 13 | 999% | 13 | D | | | | | | | | | | | | | | |
12/2/20 17:01 | 11/30/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | S.d | -5,844 | 456.49 | 0 | -13 | -50 | 13 | D | | | | | | | | | | | | | | |
11/12/20 17:01 | 11/10/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson Rebecca M | ME | D | | M.d | 502 | 85.00 | 0 | 6 | 67 | 15 | D | | | | | | | | | | | | | | |
11/12/20 17:01 | 11/10/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Henderson Rebecca M | ME | D | | S.d | -2,573 | 435.91 | 0 | -6 | -29 | 15 | D | | | | | | | | | | | | | | |
11/10/20 19:02 | 11/6/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S | -4,762 | 476.25 | 0 | -10 | -19 | 43 | I | | | | | | | | | | | | | | |
11/10/20 19:01 | 11/6/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | -3,041 | 470.01 | 0 | -6 | -1 | 720 | D | | | | | | | | | | | | | | |
11/9/20 17:01 | 11/5/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -2,443 | 469.32 | 0 | -5 | -11 | 41 | D | | | | | | | | | | | | | | |
11/9/20 17:01 | 11/6/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 200 | 69.68 | 0 | 3 | 7 | 41 | D | | | | | | | | | | | | | | |
11/6/20 17:07 | 11/5/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S | -986 | 470.08 | 0 | -2 | -21 | 8 | D | | | | | | | | | | | | | | |
11/6/20 17:07 | 11/4/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | M.d | 2,881 | 79.54 | 0 | 36 | 219 | 53 | D | | | | | | | | | | | | | | |
11/6/20 17:07 | 11/4/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO | S.d | -17,074 | 471.44 | 0 | -36 | -41 | 53 | D | | | | | | | | | | | | | | |
11/6/20 17:06 | 11/4/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -12,469 | 469.20 | 0 | -27 | -4 | 726 | D | | | | | | | | | | | | | | |
11/5/20 19:51 | 11/3/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 202 | 70.92 | 0 | 3 | 189 | 4 | D | | | | | | | | | | | | | | |
11/5/20 19:51 | 11/3/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -578 | 443.00 | 0 | -1 | -23 | 4 | D | | | | | | | | | | | | | | |
11/4/20 17:25 | 11/2/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.m | -8,958 | 438.43 | 0 | -20 | -3 | 753 | D | | | | | | | | | | | | | | |
9/2/20 17:00 | 8/31/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | M.d | 512 | 69.95 | 0 | 7 | 131 | 13 | D | | | | | | | | | | | | | | |
9/2/20 17:00 | 8/31/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | S.d | -2,840 | 388.19 | 0 | -7 | -36 | 13 | D | | | | | | | | | | | | | | |
8/31/20 17:18 | 8/27/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | M.dm | 1,435 | 79.54 | 0 | 18 | | 13 | D | | | | | | | | | | | | | | |
8/31/20 17:18 | 8/27/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Twigge Giovani | ME | O | CORPORAT | S.dm | -6,966 | 386.19 | 0 | -18 | -58 | 13 | D | | | | | | | | | | | | | | |
8/24/20 17:05 | 8/20/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 1,221 | 67.85 | 0 | 18 | 2 | 820 | D | | | | | | | | | | | | | | |
8/24/20 17:05 | 8/20/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S.d | -6,887 | 382.62 | 0 | -18 | -2 | 820 | D | | | | | | | | | | | | | | |
8/21/20 17:00 | 8/20/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 238 | 63.95 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
8/21/20 17:00 | 8/20/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,424 | 382.61 | 0 | -4 | -57 | 3 | D | | | | | | | | | | | | | | |
8/20/20 17:01 | 8/19/20 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | CVP,Gen. | M.d | 100 | 206.94 | 0 | 0 | 124 | 1 | D | | | | | | | | | | | | | | |